UNAUDITED CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Sub Total	Noncontrolling Interest	Total
Beginning balance, shares at Jul. 31, 2019		78,608,419
Beginning balance, value at Jul. 31, 2019		$ 78,608	$ 408,550,211	$ (418,727,875)	$ 797,216	$ (9,301,840)	$ 16,974,439	$ 7,672,599
Stock compensation expense, value			787,458			787,458		787,458
Issuance of common stock payable, shares		296,793
Issuance of common stock payable, value		$ 297	921,598			921,895		921,985
Conversion of debt to equity, shares		1,164,190
Conversion of debt to equity, value		$ 1,164	1,735,673			1,736,837		1,736,837
Issuance of common stock for acquisitions, shares		960,000
Issuance of common stock for acquisitions, value		$ 960	1,150,992			1,151,952		1,151,952
Reduction of derivative liabilities			1,911,487			1,911,487		1,911,487
Settlement of derivative liability from exercise of warrants
Cancellation of shares, shares		(20,375,900)
Cancellation of shares, value		$ (20,376)	20,376
Purchase of shares in subsidiary			1,987,390			1,987,390	(1,987,390)
Issuance of stock options
Currency translation adjustment					(294)	(294)		(294)
Net loss				(9,125,945)		(9,125,945)	(186,602)	(9,312,547)
Ending balance, shares at Oct. 31, 2019		60,653,502
Ending balance, vlaue at Oct. 31, 2019		$ 60,653	417,065,185	(427,853,820)	796,922	(9,931,060)	14,800,447	4,869,387
Beginning balance, shares at Jul. 31, 2020		82,251,801
Beginning balance, value at Jul. 31, 2020		$ 82,251	429,744,379	(452,062,905)	780,296	(21,455,979)	9,497,709	(11,958,270)
Stock compensation expense, shares		51,130
Stock compensation expense, value		$ 51	1,221,801			1,221,852		1,221,852
Issuance of common stock payable, shares		3,529,415
Issuance of common stock payable, value		$ 3,529	1,469,297			1,472,826		1,472,826
Conversion of debt to equity, shares		5,860,255
Conversion of debt to equity, value		$ 5,860	1,121,982			1,127,842		1,127,842
Reduction of derivative liabilities			538,084			538,084		538,084
Issuance of common stock and warrants with attributed derivative liability from PIPE offering, shares		5,102,040
Issuance of common stock and warrants with attributed derivative liability from PIPE offering, value		$ 5,102	(19,729,318)			(19,724,216)		(19,724,216)
Deemed dividend related to issuance of warrants containing derivative liabilities			1,850,000	(1,850,000)
Settlement of derivative liability from exercise of warrants			1,840,530			1,840,530		1,840,530
Sale of common stock, shares		2,100,000
Sale of common stock, value		$ 2,100	354,610			356,710		356,710
Exercise of Series D warrants, shares		9,142,973
Exercise of Series D warrants, value		$ 9,144				9,144		9,144
Currency translation adjustment					(2,202)	(2,202)		(2,202)
Net loss				(10,730,692)		(10,730,692)	(258,384)	(10,989,076)
Ending balance, shares at Oct. 31, 2020		108,037,614
Ending balance, vlaue at Oct. 31, 2020		$ 108,037	$ 418,411,365	$ (464,643,597)	$ 778,094	$ (45,346,101)	$ 9,239,325	$ (36,106,776)